Cannabis Use Disorder Linked to Lower Pancreatic Cancer Detection in Pancreatitis Patients
Among patients with chronic pancreatitis, cannabis use disorder was associated with a 74% lower rate of pancreatic cancer detection but a slight increase in acute flare-ups.
Quick Facts
What This Study Found
After propensity score matching (6,858 per group), CUD was associated with significantly reduced pancreatic cancer detection (67 vs. 274 cases; HR 0.263, 95% CI 0.202-0.344, p<0.001) but a modest increase in acute pancreatitis flare risk (HR 1.102, 95% CI 1.043-1.166, p=0.001). Results were consistent in sensitivity analysis adjusting for opioid use disorder.
Key Numbers
10,864 CUD patients and 42,160 controls before matching; 6,858 per group after matching. PC: 67 vs. 274 cases (HR 0.263). AP flares: HR 1.102. Mean follow-up shorter in CUD (736±422 vs 896±368 days).
How They Did This
Retrospective cohort study using TriNetX database identifying adults with chronic pancreatitis stratified by CUD status. Propensity score matching (1:1) for demographics, behavioral factors, and comorbidities. Cox proportional hazards regression for primary (PC incidence) and secondary (AP flare) outcomes.
Why This Research Matters
Chronic pancreatitis patients face elevated pancreatic cancer risk. If cannabis use truly reduces that risk, it could inform chemoprevention strategies — though the finding may also reflect differences in detection or follow-up.
The Bigger Picture
The dramatically lower pancreatic cancer rate in CUD patients is striking but needs careful interpretation. Shorter follow-up in the CUD group and potential differences in healthcare engagement could partly explain the finding — or cannabinoids may genuinely affect pancreatic carcinogenesis.
What This Study Doesn't Tell Us
Retrospective database study with inherent coding biases. Shorter follow-up in CUD group may miss later cancers. 'Detection' during follow-up differs from true incidence. Cannot determine mechanism. CUD is not equivalent to all cannabis use.
Questions This Raises
- ?Is the lower cancer rate due to biological protection, shorter follow-up, or less healthcare engagement?
- ?Could cannabinoids directly inhibit pancreatic carcinogenesis?
- ?Would prospective studies with equal follow-up show the same pattern?
Trust & Context
- Key Stat:
- Evidence Grade:
- Large matched cohort with consistent sensitivity analysis, but retrospective design and shorter CUD follow-up create important interpretive caveats.
- Study Age:
- Published 2026 using TriNetX multicenter database.
- Original Title:
- Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study.
- Published In:
- Journal of gastrointestinal cancer, 57(1), 14 (2026)
- Authors:
- Maan, Muhammad Hassaan Arif, Maan, Soban, Ahmad, Muhammad Mursaleen, Goyal, Ritik Mahaveer, Khan, Sunnia, Waleed, Muhammad, Qureshi, Imran, Hajifathalian, Kaveh, Al-Khazraji, Ahmed
- Database ID:
- RTHC-08451
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Could cannabis reduce pancreatic cancer risk?
In this large database study, chronic pancreatitis patients with cannabis use disorder had 74% fewer pancreatic cancer detections. However, shorter follow-up time and potential differences in healthcare engagement in the cannabis group mean this finding needs careful prospective verification.
Does cannabis affect pancreatitis?
The study found cannabis use disorder was associated with a small but significant increase in acute pancreatitis flare-ups (10% higher risk). So while the cancer finding is intriguing, cannabis may not be entirely beneficial for pancreatic health.
Read More on RethinkTHC
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cross-addiction-quit-weed-start-drinking
- is-weed-addictive
- is-weed-addictive-science
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-vape-pen-addiction
- cannabis-and-ibs-gut-health-inflammation
- cannabis-and-crohns-disease-gastroenterology
Cite This Study
https://rethinkthc.com/research/RTHC-08451APA
Maan, Muhammad Hassaan Arif; Maan, Soban; Ahmad, Muhammad Mursaleen; Goyal, Ritik Mahaveer; Khan, Sunnia; Waleed, Muhammad; Qureshi, Imran; Hajifathalian, Kaveh; Al-Khazraji, Ahmed. (2026). Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study.. Journal of gastrointestinal cancer, 57(1), 14. https://doi.org/10.1007/s12029-025-01383-w
MLA
Maan, Muhammad Hassaan Arif, et al. "Cannabis Use Disorder and Risk of Pancreatic Cancer in Patients with Chronic Pancreatitis: a Multicenter Retrospective Cohort Study.." Journal of gastrointestinal cancer, 2026. https://doi.org/10.1007/s12029-025-01383-w
RethinkTHC
RethinkTHC Research Database. "Cannabis Use Disorder and Risk of Pancreatic Cancer in Patie..." RTHC-08451. Retrieved from https://rethinkthc.com/research/maan-2026-cannabis-use-disorder-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.